Skip to content
GC
Company

Updated:

GENAERA CORP

GENAERA CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000880431, and its reported industry is...

Overview

GENAERA CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000880431, and its reported industry is Biological Products, (No Diagnostic Substances). The retained history contains 12 filings, including SC 13G filed on 2009-06-18. Each filing retains its accession, filing date and original SEC document link. This historical evidence does not establish current registration, listing, ownership or financial condition.

Company overview

Legal name
GENAERA CORP
Former names in filing history
MAGAININ PHARMACEUTICALS INC (1994-02-14 to 2001-02-13)
Classification
Company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
Plymouth Meeting, PA, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0000880431

Recent SEC filings

FormFiledPeriodFiling
SC 13G—SC13G
8-KForm 8-K
8-KForm 8-K
8-KForm 8-K
SC 13G—SCHEDULE 13G
8-KForm 8-K
8-KForm 8-K
8-KForm 8-K
8-KForm 8-K
8-KForm 8-K
8-KForm 8-K
10-KGENAERA CORPORATION -- FORM 10-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research GENAERA CORP in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

GENAERA CORP | Plymouth Meeting Company | Altss